ProQR Therapeutics Virtual Investor Event: Expanding the Axiomer™ RNA Editing Opportunity Beyond AX-0810
| DATE: | April 8, 2026 |
|---|---|
| TIME: | 10:00 AM EDT |
| LOCATION: | Virtual |
About The Event
Ahead of the anticipated target engagement data for AX-0810 in the first half of 2026, the Company will showcase ProQR’s broader RNA editing pipeline at this event, announce new programs that will have clinical data readouts in the runway, and unveil the primary indication for AX-0810.
A Q&A session with covering analysts and Managaement will follow the formal presentation